__NUXT_JSONP__("/drugs/Abagovomab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"792921-10-9",chebiId:b,chemicalFormula:b,definition:"A murine IgG1 monoclonal anti-idiotype antibody, containing a variable antigen-binding region that functionally mimics the three-dimensional structure of a specific epitope on the ovarian cancer tumor-associated antigen CA-125, with potential antineoplastic activity. With a variable antigen-binding region that acts as a surrogate antigen for CA-125, abagovomab may stimulate the host immune system to elicit humoral and cellular immune responses against CA-125-positive tumor cells, resulting in inhibition of tumor cell proliferation.",fdaUniiCode:"3YK0326U7X",identifier:"C26449",preferredName:a,semanticType:"Immunologic Factor",subclassOf:["C129822","C2590"],synonyms:["ABAGOVOMAB",a,"Monoclonal Antibody ACA125 Anti-Idiotype Vaccine","VaccinOvar"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAbagovomab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Abagovomab","","2021-10-30T13:37:59.443Z")));